David Krag
Overview
Explore the profile of David Krag including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giroux K, Krag D, Single R, Prytherch S, White S, Niknaum S
Am J Drug Alcohol Abuse
. 2025 Feb;
:1-7.
PMID: 39993010
Literature regarding opioid use disorder (OUD) is often difficult for nonscientific communities to access. The OUD database on RefBin categorizes scientific findings and may facilitate access to information regarding OUD....
2.
Sozen S, Krag D, Milliren C
J Opioid Manag
. 2023 Oct;
19(7):123-133.
PMID: 37879667
Background: Pregnant and post-partum women with opioid dependence are an extremely vulnerable population within correctional facilities. A significant number of maternal inmates, however, still lack adequate provision of medications for...
3.
Torfs-Leibman C, Ashikaga T, Krag D, Lunna S, Robtoy S, Bombardier R
BMJ Health Care Inform
. 2022 Nov;
29(1).
PMID: 36351703
Background And Objectives: Literature review using search engines results in a list of manuscripts but does not provide the content contained in the manuscripts. Our goal was to evaluate user...
4.
Lunna S, Flinn I, Prytherch J, Torfs-Leibman C, Robtoy S, Bansak M, et al.
BMJ Health Care Inform
. 2022 Mar;
29(1).
PMID: 35264375
Introduction: The number of new biomedical manuscripts published on important topics exceeds the capacity of single persons to read. Integration of literature is an even more elusive task. This article...
5.
Nathanson S, Krag D, Kuerer H, Newman L, Brown M, Kerjaschki D, et al.
Clin Exp Metastasis
. 2018 May;
35(5-6):443-454.
PMID: 29796854
Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by which tumor...
6.
Zhao F, Misra Y, Li D, Wadsworth M, Krag D, Weaver D, et al.
Int J Oncol
. 2018 Apr;
52(6):2069-2078.
PMID: 29620155
Oct3/4, a transcription factor specifically expressed in mammalian totipotent embryonic stem and germ cells, has a critical role in the regulation and maintenance of pluripotency and self-renewal. However, reactivation of...
7.
Asadi M, Krag D
Int J Surg
. 2016 Nov;
36(Pt A):332-334.
PMID: 27856352
Almost all recent studies confirmed internal mammary sentinel lymph node biopsy (IM-SLNB) as an accurate and valuable technique to determine stage, prognosis, and best treatment option in breast cancer patients....
8.
Sun Y, Shukla G, Pero S, Currier E, Sholler G, Krag D
Biotechniques
. 2015 Aug;
52(4).
PMID: 26307247
Antibodies are important drugs for treating cancer and there is strong rationale for using multiple antibodies to improve outcomes. We labeled two breast cancer binding antibodies, anti-ErbB2 and anti-EpCAM, with...
9.
Pesek S, Ashikaga T, Krag L, Krag D
World J Surg
. 2012 May;
36(9):2239-51.
PMID: 22569745
Background: In sentinel node surgery for breast cancer, procedural accuracy is assessed by calculating the false-negative rate. It is important to measure this since there are potential adverse outcomes from...
10.
James T, McCahill L, Ratliff J, Ashikaga T, Single R, Sheehey-Jones J, et al.
Breast J
. 2009 Jul;
15(5):524-6.
PMID: 19624412
Neoadjuvant systemic therapy (NST) for operable breast cancer can increase the options for conservative surgery in patients with breast cancer. We performed an analysis of a breast cancer outcomes database...